8 min listen
Cost-effectiveness of Artificial Intelligence–Based Retinopathy of Prematurity Screening
Cost-effectiveness of Artificial Intelligence–Based Retinopathy of Prematurity Screening
ratings:
Length:
10 minutes
Released:
Mar 17, 2022
Format:
Podcast episode
Description
Interview with J. Peter Campbell, MD, author of Cost-effectiveness of Artificial Intelligence–Based Retinopathy of Prematurity Screening. Hosted by Neil Bressler, MD.
Released:
Mar 17, 2022
Format:
Podcast episode
Titles in the series (100)
Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations: Safety and Efficacy in 15 Children and Adults Followed Up to 3 Years: Interview with Samuel G. Jacobson, MD, PhD, author of Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations: Safety and Efficacy in 15 Children and Adults Followed Up to 3 Years by JAMA Ophthalmology Author Interviews